Should NIH Change Its Name?

Readers of The Scientist by now should be familiar with the aims of Research!America, the Alexandria, Va.-based national nonprofit advocacy organization for biomedical research that was founded in 1989. Chairing its annual membership meeting on March 12, former Congressman Paul Rogers discussed the remarkable progress Research!America has made in advancing the cause of biomedical research. Mary Woolley, the organization's president, reported on the public's increased awareness of the need for g

Written byEugene Garfield
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Readers of The Scientist by now should be familiar with the aims of Research!America, the Alexandria, Va.-based national nonprofit advocacy organization for biomedical research that was founded in 1989. Chairing its annual membership meeting on March 12, former Congressman Paul Rogers discussed the remarkable progress Research!America has made in advancing the cause of biomedical research. Mary Woolley, the organization's president, reported on the public's increased awareness of the need for greater funding of biomedical research (M. Woolley, The Scientist, March 18, 1996, page 10).

This grass-roots awareness has become apparent to both Republican and Democratic members of Congress. While the latter have been the traditional boosters of National Institutes of Health funding, some Republicans have recently taken up the cause with great fervor. Republican members of the House of Representatives such as John E. Porter (Illinois), as well as Sens. Arlen Specter (Pennsylvania) and Phil Gramm (Texas), among others, have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies